Pfizer Recalls Relpax Tablets Due to Incorrect Strength Labeling
Pfizer is recalling Relpax 40 mg tablets because secondary packaging incorrectly lists the strength as 20 mg. The error is on one side of the carton.
- Product
- Relpax (eletriptan HBr) 40 mg, a) 12 tablets 2 cards x six 40 mg tablets per blister pack, NDC 0049-2340-05; b) 6 tablets 1 card x six 40 mg tablets per blister pack, NDC 0049-2340-45, Rx Only, Made in Ireland, Distributed by Roerig, Division of Pfizer Inc, NY NY 10017.
- Category
- Drug
- Distribution
- Distributed nationwide